Frontlight ResearchEarly access
Trial site
King George Hospital
- 7running trials
- 3closed trials
The trials here
What the 11 trials at this site are about, from their registry records.
- Conditions
- Heart failure3 trials
- Ovarian cancer2 trials
- Type 2 diabetes2 trials
- Atrial fibrillation1 trial
- Chronic kidney disease1 trial
- Coronary artery disease1 trial
- High blood pressure1 trial
- Rheumatoid arthritis1 trial
- Stroke1 trial
- Phase
- Phase 39 trials
- Phase 22 trials
- Status
- Active, not recruiting4 trials
- Completed3 trials
- Recruiting3 trials
- Suspended1 trial
- Lead sponsor
- Boehringer Ingelheim3 trials
- Janssen Research & Development, LLC3 trials
- Alfasigma S.p.A.1 trial
- Bayer1 trial
- CanariaBio Inc.1 trial
- and 2 more
Running trials
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Heart failure2 recruiting
- Ovarian cancer1 recruiting
Closed trials
Completed
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome
Completed
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026